An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02324491 · TERMINATED
Trial details
- NCT number
- NCT02324491
- Sponsor
- Zafgen, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.